Progress in Mind Go to Progress in Mind Main channel featuring interviews, articles, congress highlights and much more. Go to channel
Masennus, Skitsofrenia Lukuaika: 4 minuutti(s) Kongressin kohokohdatArtikla Highlights from the 36th European College of Neuropsychopharmacology – ECNP – Congress The annual European College of Neuropsychopharmacology (ECNP) Congress is Europe’s largest... Content action menuShareTestTest 2Test 3
Kaksisuuntainen mieliala, Skitsofrenia Lukuaika: 5 minuutti(s) Kongressin kohokohdatArtikla Exploring the transmission of mental illness from parents to children A family history of severe mental illness (SMI) is a known risk factor for the development of SMI... Content action menuShareTestTest 2Test 3
Mental health Lukuaika: 5 minuutti(s) Kongressin kohokohdatArtikla Poor Heart Health Outcomes in Patients with Mental Illness Patients living with serious mental illnesses (SMI) have high rates of cardiovascular morbidity and... Content action menuShareTestTest 2Test 3
Migreeni Lukuaika: 6 minuutti(s) Satelliitti-symposiumArtikla Migraine control and the optimal treatment pathway More than one billion individuals across the world are affected by migraine.1 Headache disorders,... Content action menuShareTestTest 2Test 3
Masennus, Skitsofrenia Lukuaika: 3 minuutti(s) Kongressin kohokohdat Measurement-based care: How can we improve outcomes for patients with depression and schizophrenia Measurement-based care (MBC) can improve outcomes and reduce health disparities for serious mental... Content action menuShareTestTest 2Test 3
Mental health Lukuaika: 4 minuutti(s) Kongressin kohokohdat How are genes involved in tailoring psychiatric treatment? Psychiatrists need an understanding of genome-wide association studies (GWAS), pharmacogenomics,... Content action menuShareTestTest 2Test 3
Alzheimerin tauti Lukuaika: 3 minuutti(s) Kongressin kohokohdat Which tau biomarkers are most informative in AD? Aggregates of hyperphosphorylated and C-terminally truncated microtubule-associated tau protein are... Content action menuShareTestTest 2Test 3
Alzheimerin tauti Lukuaika: 3 minuutti(s) Kongressin kohokohdat Which populations are most vulnerable to Alzheimer’s disease and why? Populations most vulnerable to Alzheimer’s disease (AD) need to be better represented in AD... Content action menuShareTestTest 2Test 3